Page last updated: 2024-10-17

citric acid, anhydrous and Hypertrophy

citric acid, anhydrous has been researched along with Hypertrophy in 2 studies

Citric Acid: A key intermediate in metabolism. It is an acid compound found in citrus fruits. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability.
citric acid : A tricarboxylic acid that is propane-1,2,3-tricarboxylic acid bearing a hydroxy substituent at position 2. It is an important metabolite in the pathway of all aerobic organisms.

Hypertrophy: General increase in bulk of a part or organ due to CELL ENLARGEMENT and accumulation of FLUIDS AND SECRETIONS, not due to tumor formation, nor to an increase in the number of cells (HYPERPLASIA).

Research Excerpts

ExcerptRelevanceReference
"We investigated the preventive effects of long-term treatment with the angiotensin converting enzyme inhibitor ramipril on myocardial left ventricular hypertrophy and capillary length density in spontaneously hypertensive rats."3.68Effect of early onset angiotensin converting enzyme inhibition on myocardial capillaries. ( Bock, P; Gohlke, P; Lamberty, V; Linz, W; Mall, G; Mattfeldt, T; Schölkens, BA; Unger, T, 1992)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
COOPER, JF1
IMFELD, H1
Unger, T1
Mattfeldt, T1
Lamberty, V1
Bock, P1
Mall, G1
Linz, W1
Schölkens, BA1
Gohlke, P1

Other Studies

2 other studies available for citric acid, anhydrous and Hypertrophy

ArticleYear
The role of citric acid in the physiology of the prostate: a preliminary report.
    Transactions. American Urological Association. Western Section, 1958, Volume: 25

    Topics: Citrates; Citric Acid; Humans; Hypertrophy; Male; Prostate; Prostatic Hyperplasia; Prostatic Neoplas

1958
Effect of early onset angiotensin converting enzyme inhibition on myocardial capillaries.
    Hypertension (Dallas, Tex. : 1979), 1992, Volume: 20, Issue:4

    Topics: Administration, Oral; Age Factors; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; A

1992